VideoHIV19th INTEREST 2025Abstract # 24 Improvement in Drug Concentrations After an Adherence Intervention: Data From the RETAIN StudyView Video
SlidesetHIV19th INTEREST 2025Abstract # 24 Improvement in Drug Concentrations After an Adherence Intervention: Data From the RETAIN Study - Catherine OrrellView Slideset
RBRobert BiesPharmD, PhD, FISoPVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Pharmacokinetic Considerations of Long-Acting Anti-Infective Administration During Pregnancy - Robert BiesView Video
SHSarah HakMD, PhDVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Monoclonal Antibodies for RSV Prevention - Sarah HakView Video
DKDaniel KuritzkesMDVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Therapies for Emerging Infections: Insights from COVID-19 - Daniel KuritzkesView Video
FVFrançois VenterMD, FCP, PhDVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Anti-Infectives in Resource-Limited Settings - François VenterView Video
KSKimberly ScarsiPharmD, MS, FCCPVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Clinical Development of Long-Acting Formulations for Treatment and Prevention of Tuberculosis - Kimberly ScarsiView Video
NRNatella RakhmaninaMD, PhD, FAAP, FCP, AAHIVSVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025The Long-Acting Anti-Infective Agents for Children and Adolescents: Are We Nearly There Yet? - Natella RakhmaninaView Video
Video1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Getting It Right This Time: The Impact of PEPFAR Stop Work Orders on Injectable PrEP and Implications for LEN Rollout - Stacey HannahView Video
Video1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Antiretroviral Monoclonal Antibodies: Revolutionizing HIV Prevention - Huub GelderblomView Video
KSRKellie Schoolar ReynoldsPharmDVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Regulatory Considerations for Long-Acting Anti-Infectives: Challenges and Opportunities - Kellie Schoolar ReynoldsView Video
CFCharles FlexnerMDVideo1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Anti-Infectives: Where Do We Stand? - Charles FlexnerView Video
